Cosifarma SRL
Cosifarma reported total assets of €2.69m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026).
The score of Cosifarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +44 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cosifarma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 11 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Cosifarma's financial analysis
- Solvency57.7%sector median: 52.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cosifarma
Cosifarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0898.370.052
- VAT number
- BE0898370052
- Peppol
- Registered · 0208:0898370052 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Jun 2008
- Registered office
- 2070 Beveren-Kruibeke-Zwijndrecht
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Office administrative and support activities (NACE 82100)
Cosifarma (SRL) has been based in Beveren-Kruibeke-Zwijndrecht since 2008, active in: office administrative and support activities. For 2025, it reports a net profit of 13,633 € and equity of €1.56m; its revenue is not published. Its solvency stands at 57.7%, above the median of its sector (52.8%).
Companies similar to Cosifarma
Companies in the same business, of comparable size and area, outside its group.
- MJ Management Office administrative and support activities Kontich · balance sheet €2.37m
- Carjen Invest Other information service activities Hasselt · balance sheet €2.78m
- FST Projects Activities of holding companies Sint-Martens-Latem · balance sheet €1.67m
- HPM Holding Business and other management consultancy activities Awans · balance sheet €2.62m
- SCTM Business and other management consultancy activities Hasselt · balance sheet 304,103 €
- Info-B Business and other management consultancy activities Middelkerke · balance sheet €3.10m
- Paul VD Mierop Business and other management consultancy activities Rijkevorsel · balance sheet €2.14m
- Amani Business and other management consultancy activities Ghent · balance sheet €2.14m
Frequently asked questions about Cosifarma
What is the revenue of Cosifarma?
Cosifarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cosifarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0898370052 for Cosifarma, if the company is VAT-registered. Its company number (CBE) is 0898.370.052.
Where is the registered office of Cosifarma?
According to the CBE register, the registered office of Cosifarma is in 2070 Beveren-Kruibeke-Zwijndrecht.
What is the equity of Cosifarma?
At the close of the 2025 financial year, the equity of Cosifarma amounts to 1,555,719 €, a solvency of 57.7% of total assets.
Who manages Cosifarma?
The register lists 2 active mandates at Cosifarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cosifarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →